Generic Substitution in the Treatment of Epilepsy: Case Evidence of Breakthrough Seizures
Neurol 71:525-530, Berg,M.J.,et al., 2008
HIV-Protease Inhibitors
NEJM 338:1281-1292, Flexner,C., 1998
Subarachnoid Hemorrhage
NEJM 377:257-266, Lawton, M.T. & Vates, G.E., 2017
Zolpidem for the Treatment of Neurologic Disorders
JAMA Neurol 74:1130-1139, Bomalaski, M.N.,et al, 2017
Making Every Word Count for Nonresponsive Patients
JAMA Neurol 70:1235-1241, Naci, L. & Owen, A.M., 2013
Central Nervous System Injury Associated with Cardiac Surgery
Lancet 368:694-703, Newman,M.F.,et al, 2006
Brain Metastases
The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004
Cost Effectiveness of Oral Compared with IV Antibiotic Therapy for Pts with Early Lyme Dis or Lyme Arthritis
NEJM 337:357-363, Eckman,M.H.,et al, 1997
Rational Polypharmacy in the Treatment of Epilepsy
(Ed) , Neurol (suppl) 45:S1-S38., Wilder,B.J., 1995
30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients with Alzheimer's Disease
JAMA 271:985-991, 10231994., Knapp,M.J.,et al, 1994
Recovery of Patients after Four Months or More in the Persistent Vegetative State
BMJ 306:1597-1600, Andrews,K., 1993
Patients in the Persistent Vegetative State:Problems in Their Long Term Management
BMJ 306:1600-1603, Andrews,K., 1993
An Aggressive Approach to Massive Middle Cerebral Artery Infarction
Arch Neurol 50:1293-1297, Kalia,K.K.&Yonas,H., 1993
Managing the Persistent Vegetative State, Early, Skilled Treatment Offers the Best Hope for Optimal Recovery
BMJ 305:486-487, Andrews,K., 1992